José Saenz, MD, PhD, awarded the 2022 Young Physician Scientist Award on behalf of the ASCI

José Saenz, MD, PhD, awarded the 2022 Young Physician Scientist Award on behalf of the ASCI
Dr. José Sáenz trained as a physician-scientist at the Washington University in St. Louis School of Medicine where he learned to frame basic science questions in a broader clinical context. While his initial research interests were varied, he ultimately became drawn to microbial pathogenesis and the ability of bacteria to manage and exploit interactions with […]

Kory Lavine, MD, PhD, elected to the ASCI

Kory Lavine, MD, PhD, elected to the ASCI
Dr. Kory Lavine, an associate professor of medicine in the Cardiovascular Division, is a cardiologist whose research is focused on understanding the role of the body’s immune system in the development and treatment of heart failure. He is developing new methods to image heart inflammation and crafting therapeutic strategies aimed at limiting damaging inflammation and promoting […]

Shawn Demehri, MD, PhD, elected to the ASCI

Shawn Demehri, MD, PhD, elected to the ASCI
Mass General Cancer Center physician-scientist Shawn Demehri, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI) as part of ASCI’s new class of members for 2022. Dr. Demehri is the Director for the High Risk Skin Cancer Clinic, he is a board-certified dermatologist and a principal investigator at the Center for Cancer Immunology, and Cutaneous Biology […]

Dr. Kian-Huat Lim identifies drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.

Dr. Kian-Huat Lim identifies drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.
Pancreatic cancer is extremely difficult to treat. By the time it is detected, the cancer often has reached an advanced stage, and patients usually do not survive longer than one year after diagnosis. An aggressive chemotherapy regimen is the first-line treatment, but the side effects can be severe, and many tumors stop responding to treatment. […]

Dr. Leo Shmuylovich awarded prestigious “high risk, high reward” grant

Dr. Leo Shmuylovich awarded prestigious “high risk, high reward” grant
Dr. Schmuylovich is one of four scientists at Washington University School of Medicine in St. Louis to have been awarded prestigious grants from the National Institutes of Health (NIH) aimed at supporting the researchers’ innovative and impactful biomedical and behavioral research. The grants are among a total of 106 such grants awarded to scientists recognized […]

Dr. Jeff Henderson authors study showing blood cancer patients with COVID-19 fare better with convalescent plasma

Dr. Jeff Henderson authors study showing blood cancer patients with COVID-19 fare better with convalescent plasma
Dr. Jeff Henderson authors a new study that shows that such plasma from recovered COVID-19 patients can dramatically increase the likelihood of survival for blood cancer patients hospitalized with COVID-19. A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve […]

Dr. Max Petersen awarded Endocrine Fellows Foundation grant

Dr. Max Petersen awarded Endocrine Fellows Foundation grant
Max Petersen, MD, PhD was awarded the Endocrine Fellows Foundation’s Fellow Research Grant. His research project, titled “Muscle bioactive lipids in metabolically healthy and unhealthy obesity,” has been awarded a $5,000 grant from the Endocrine Fellows Foundation. The grant is intended to cover research over a 1-year time span. For more information, please see this […]